Keywords: gilead, profits, up, hiv, franchise, sales, drugmaker

Gilead profits up 9% on HIV franchise sales

Article | 28 July 2008

Print This

US drugmaker Gilead Sciences has increased its net income for the quarter ending June 30, 2008, to $442.8 million, up 9% on the same ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in